Zoltan Pos, Ph.D. - Publications

Affiliations: 
2005 Semmelweis Egyetem, Hungary 
Area:
Cell Biology, Oncology

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Érsek B, Silló P, Cakir U, Molnár V, Bencsik A, Mayer B, Mezey E, Kárpáti S, Pós Z, Németh K. Melanoma-associated fibroblasts impair CD8+ T cell function and modify expression of immune checkpoint regulators via increased arginase activity. Cellular and Molecular Life Sciences : Cmls. PMID 32328671 DOI: 10.1007/S00018-020-03517-8  0.424
2018 Lupsa N, Érsek B, Horváth A, Bencsik A, Lajkó E, Silló P, Oszvald Á, Wiener Z, Reményi P, Mikala G, Masszi T, Buzás EI, Pós Z. Skin-homing CD8+ T cells preferentially express GPI-anchored peptidase inhibitor 16, an inhibitor of cathepsin K. European Journal of Immunology. PMID 30365157 DOI: 10.1002/Eji.201847552  0.342
2016 Érsek B, Lupsa N, Pócza P, Tóth A, Horváth A, Molnár V, Bagita B, Bencsik A, Hegyesi H, Matolcsy A, Buzás EI, Pós Z. Unique patterns of CD8+ T-cell-mediated organ damage in the Act-mOVA/OT-I model of acute graft-versus-host disease. Cellular and Molecular Life Sciences : Cmls. PMID 27137185 DOI: 10.1007/S00018-016-2237-7  0.355
2014 Thomas JM, Pos Z, Reinboth J, Wang RY, Wang E, Frank GM, Lusso P, Trinchieri G, Alter HJ, Marincola FM, Thomas E. Differential responses of plasmacytoid dendritic cells to influenza virus and distinct viral pathogens. Journal of Virology. 88: 10758-66. PMID 25008918 DOI: 10.1128/Jvi.01501-14  0.356
2014 Longo DM, Louie B, Ptacek J, Friedland G, Evensen E, Putta S, Atallah M, Spellmeyer D, Wang E, Pos Z, Marincola FM, Schaeffer A, Lukac S, Railkar R, Beals CR, et al. High-dimensional analysis of the aging immune system: verification of age-associated differences in immune signaling responses in healthy donors. Journal of Translational Medicine. 12: 178. PMID 24952610 DOI: 10.1186/1479-5876-12-178  0.306
2014 Liu Q, Tomei S, Ascierto ML, De Giorgi V, Bedognetti D, Dai C, Uccellini L, Spivey T, Pos Z, Thomas J, Reinboth J, Murtas D, Zhang Q, Chouchane L, Weiss GR, et al. Melanoma NOS1 expression promotes dysfunctional IFN signaling. The Journal of Clinical Investigation. 124: 2147-59. PMID 24691438 DOI: 10.1172/Jci69611  0.413
2014 Pos Z, Spivey TL, Liu H, Sommariva M, Chen J, Wunderlich JR, Parisi G, Tomei S, Ayotte BD, Stroncek DF, Malek JA, Robbins PF, Rivoltini L, Maio M, Chouchane L, et al. Longitudinal study of recurrent metastatic melanoma cell lines underscores the individuality of cancer biology. The Journal of Investigative Dermatology. 134: 1389-96. PMID 24270663 DOI: 10.1038/Jid.2013.495  0.305
2013 Gyöngyösi A, Szatmari I, Pap A, Dezso B, Pos Z, Széles L, Varga T, Nagy L. RDH10, RALDH2, and CRABP2 are required components of PPARγ-directed ATRA synthesis and signaling in human dendritic cells. Journal of Lipid Research. 54: 2458-74. PMID 23833249 DOI: 10.1194/Jlr.M038984  0.366
2012 Longo DM, Louie B, Mathi K, Pos Z, Wang E, Hawtin RE, Marincola FM, Cesano A. Racial differences in B cell receptor signaling pathway activation. Journal of Translational Medicine. 10: 113. PMID 22672557 DOI: 10.1186/1479-5876-10-113  0.354
2012 Spivey TL, De Giorgi V, Zhao Y, Bedognetti D, Pos Z, Liu Q, Tomei S, Ascierto ML, Uccellini L, Reinboth J, Chouchane L, Stroncek DF, Wang E, Marincola FM. The stable traits of melanoma genetics: an alternate approach to target discovery. Bmc Genomics. 13: 156. PMID 22537248 DOI: 10.1186/1471-2164-13-156  0.338
2012 Longo DM, Louie B, Putta S, Evensen E, Ptacek J, Cordeiro J, Wang E, Pos Z, Hawtin RE, Marincola FM, Cesano A. Single-cell network profiling of peripheral blood mononuclear cells from healthy donors reveals age- and race-associated differences in immune signaling pathway activation. Journal of Immunology (Baltimore, Md. : 1950). 188: 1717-25. PMID 22246624 DOI: 10.4049/Jimmunol.1102514  0.358
2011 Ji Y, Pos Z, Rao M, Klebanoff CA, Yu Z, Sukumar M, Reger RN, Palmer DC, Borman ZA, Muranski P, Wang E, Schrump DS, Marincola FM, Restifo NP, Gattinoni L. Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits the formation of memory CD8+ T cells. Nature Immunology. 12: 1230-7. PMID 22057288 DOI: 10.1038/Ni.2153  0.353
2011 Ascierto ML, Worschech A, Yu Z, Adams S, Reinboth J, Chen NG, Pos Z, Roychoudhuri R, Di Pasquale G, Bedognetti D, Uccellini L, Rossano F, Ascierto PA, Stroncek DF, Restifo NP, et al. Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68. Bmc Cancer. 11: 451. PMID 22011439 DOI: 10.1186/1471-2407-11-451  0.356
2011 Gattinoni L, Lugli E, Ji Y, Pos Z, Paulos CM, Quigley MF, Almeida JR, Gostick E, Yu Z, Carpenito C, Wang E, Douek DC, Price DA, June CH, Marincola FM, et al. A human memory T cell subset with stem cell-like properties. Nature Medicine. 17: 1290-7. PMID 21926977 DOI: 10.1038/Nm.2446  0.324
2011 Longo D, Louie B, Mathi K, Pos Z, Wang E, Hawtin RE, Marincola F, Cesano A. Single Cell Network Profiling (SCNP) Reveals Race-Associated Differences in B Cell Receptor Signaling Pathway Activation Blood. 118: 1125-1125. DOI: 10.1182/Blood.V118.21.1125.1125  0.363
2010 Falus A, Pós Z, Darvas Z. Histamine in normal and malignant cell proliferation. Advances in Experimental Medicine and Biology. 709: 109-23. PMID 21618892 DOI: 10.1007/978-1-4419-8056-4_11  0.337
2010 Longo D, Evensen E, Fantl WJ, Pos Z, Marincola F, Cesano A. Single Cell Network Profiling (SCNP) of IFN-α Signaling Pathways In Peripheral Blood Mononuclear Cells From Healthy Donors: Implications for Disease Characterization, Treatment Selection, and Drug Discovery Blood. 116: 4867-4867. DOI: 10.1182/Blood.V116.21.4867.4867  0.383
2010 Dickensheets H, Sheikh F, Pos Z, Marincola F, Donnelly RP. PS1-79 COmparative analysis of responsiveness to IFN-α and IFN-λ by normal human bronchial epithelial cells and hepatocytes Cytokine. 52: 34-34. DOI: 10.1016/J.Cyto.2010.07.151  0.324
2010 Ascierto M, Worschech A, Pos Z, Rossano F, Ascierto P, Wang E, Marincola F. Variations of Vaccinia Virus' Replication in Melanoma and Lung Cell Lines Based on Different Expression of IFI6, and IFTMN2 and β-microglobin Clinical Immunology. 135. DOI: 10.1016/J.Clim.2010.03.198  0.305
2009 Tahara H, Sato M, Thurin M, Wang E, Butterfield LH, Disis ML, Fox BA, Lee PP, Khleif SN, Wigginton JM, Ambs S, Akutsu Y, Chaussabel D, Doki Y, Eremin O, ... ... Pos Z, et al. Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology. Journal of Translational Medicine. 7: 45. PMID 19534815 DOI: 10.1186/1479-5876-7-45  0.337
2008 Selleri S, Deola S, Pos Z, Jin P, Worschech A, Slezak SL, Rumio C, Panelli MC, Maric D, Stroncek DF, Wang E, Marincola FM. GM-CSF/IL-3/IL-5 receptor common beta chain (CD131) expression as a biomarker of antigen-stimulated CD8+ T cells. Journal of Translational Medicine. 6: 17. PMID 18412971 DOI: 10.1186/1479-5876-6-17  0.338
2008 Pos Z, Wiener Z, Pocza P, Racz M, Toth S, Darvas Z, Molnar V, Hegyesi H, Falus A. Histamine suppresses fibulin-5 and insulin-like growth factor-II receptor expression in melanoma. Cancer Research. 68: 1997-2005. PMID 18339882 DOI: 10.1158/0008-5472.Can-07-2816  0.606
2008 Wang E, Selleri S, Sabatino M, Monaco A, Pos Z, Worschech A, Stroncek DF, Marincola FM. Spontaneous and treatment-induced cancer rejection in humans. Expert Opinion On Biological Therapy. 8: 337-49. PMID 18294104 DOI: 10.1517/14712598.8.3.337  0.342
2008 Boer K, Helinger E, Helinger A, Pocza P, Pos Z, Demeter P, Baranyai Z, Dede K, Darvas Z, Falus A. Decreased expression of histamine H1 and H4 receptors suggests disturbance of local regulation in human colorectal tumours by histamine. European Journal of Cell Biology. 87: 227-36. PMID 18258331 DOI: 10.1016/J.Ejcb.2007.12.003  0.373
2005 Pós Z, Sáfrány G, Müller K, Tóth S, Falus A, Hegyesi H. Phenotypic profiling of engineered mouse melanomas with manipulated histamine production identifies histamine H2 receptor and rho-C as histamine-regulated melanoma progression markers. Cancer Research. 65: 4458-66. PMID 15899839 DOI: 10.1158/0008-5472.Can-05-0011  0.612
2005 Hegyesi H, Horváth B, Pállinger E, Pós Z, Molnár V, Falus A. Histamine elevates the expression of Ets-1, a protooncogen in human melanoma cell lines through H2 receptor. Febs Letters. 579: 2475-9. PMID 15848191 DOI: 10.1016/J.Febslet.2005.03.053  0.404
2004 Garaczi E, Széll M, Jánossy T, Koreck A, Pivarcsi A, Buzás E, Pos Z, Falus A, Dobozy A, Kemény L. Negative regulatory effect of histamine in DNFB-induced contact hypersensitivity. International Immunology. 16: 1781-8. PMID 15528221 DOI: 10.1093/Intimm/Dxh179  0.326
2001 Falus A, Hegyesi H, Lázár-Molnár E, Pós Z, László V, Darvas Z. Paracrine and autocrine interactions in melanoma: histamine is a relevant player in local regulation Trends in Immunology. 22: 648-652. PMID 11738976 DOI: 10.1016/S1471-4906(01)02050-6  0.45
2001 Szeberényi JB, Pállinger E, Zsinkó M, Pós Z, Rothe G, Orsó E, Szeberényi S, Schmitz G, Falus A, László V. Inhibition of effects of endogenously synthesized histamine disturbs in vitro human dendritic cell differentiation. Immunology Letters. 76: 175-82. PMID 11306145 DOI: 10.1016/S0165-2478(01)00184-5  0.394
2001 Heninger E, Falus A, Darvas Z, Szalai C, Zsinkó M, Pos Z, Hegyesi H. Both interferon (IFN)alpha and IFNgamma inhibit histidine decarboxylase expression in the HT168 human melanoma cell line. Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]. 49: 393-7. PMID 11028755 DOI: 10.1007/S000110050606  0.388
Show low-probability matches.